The effects of age on insulin dose and weight are consistent with previous reports of randomized controlled studies that evaluated insulin glargine in older (≥ 65 years) and younger (< 65 years) adults with T2D [9, 10]. This evidence concerns the gene INS and type 2 diabetes mellitus.